101 related articles for article (PubMed ID: 7490615)
1. Expression of bcl-2 in reactive and neoplastic astrocytes: lack of correlation with presence or degree of malignancy.
Krishna M; Smith TW; Recht LD
J Neurosurg; 1995 Dec; 83(6):1017-22. PubMed ID: 7490615
[TBL] [Abstract][Full Text] [Related]
2. [Relationship of bcl-2 gene expression with cell proliferation and apoptosis in human gliomas].
Yu S; Pu P; Jiang D; An T; Guan X; Yang L
Zhonghua Bing Li Xue Za Zhi; 2000 Feb; 29(1):12-5. PubMed ID: 11866884
[TBL] [Abstract][Full Text] [Related]
3. Receptor tyrosine kinase expression in astrocytic lesions: similar features in gliosis and glioma.
Kristt DA; Reedy E; Yarden Y
Neurosurgery; 1993 Jul; 33(1):106-15. PubMed ID: 7689190
[TBL] [Abstract][Full Text] [Related]
4. Protooncogene bcl-2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation.
Weller M; Malipiero U; Aguzzi A; Reed JC; Fontana A
J Clin Invest; 1995 Jun; 95(6):2633-43. PubMed ID: 7539458
[TBL] [Abstract][Full Text] [Related]
5. Human gliomas with wild-type p53 express bcl-2.
Alderson LM; Castleberg RL; Harsh GR; Louis DN; Henson JW
Cancer Res; 1995 Mar; 55(5):999-1001. PubMed ID: 7867012
[TBL] [Abstract][Full Text] [Related]
6. Role of gemistocytes in astrocytoma progression.
Watanabe K; Tachibana O; Yonekawa Y; Kleihues P; Ohgaki H
Lab Invest; 1997 Feb; 76(2):277-84. PubMed ID: 9042164
[TBL] [Abstract][Full Text] [Related]
7. Differences between phosphotyrosine accumulation and Neu/ErbB-2 receptor expression in astrocytic proliferative processes. Implications for glial oncogenesis.
Kristt DA; Yarden Y
Cancer; 1996 Sep; 78(6):1272-83. PubMed ID: 8826951
[TBL] [Abstract][Full Text] [Related]
8. Detection of tumor necrosis factor-alpha protein and messenger RNA in human glial brain tumors: comparison of immunohistochemistry with in situ hybridization using molecular probes.
Roessler K; Suchanek G; Breitschopf H; Kitz K; Matula C; Lassmann H; Koos WT
J Neurosurg; 1995 Aug; 83(2):291-7. PubMed ID: 7616275
[TBL] [Abstract][Full Text] [Related]
9. Influence of Bax or Bcl-2 overexpression on the ceramide-dependent apoptotic pathway in glioma cells.
Sawada M; Nakashima S; Banno Y; Yamakawa H; Takenaka K; Shinoda J; Nishimura Y; Sakai N; Nozawa Y
Oncogene; 2000 Jul; 19(31):3508-20. PubMed ID: 10918609
[TBL] [Abstract][Full Text] [Related]
10. Bcl-2 expression in higher-grade human glioma: a clinical and experimental study.
Fels C; Schäfer C; Hüppe B; Bahn H; Heidecke V; Kramm CM; Lautenschläger C; Rainov NG
J Neurooncol; 2000 Jul; 48(3):207-16. PubMed ID: 11100818
[TBL] [Abstract][Full Text] [Related]
11. Fas (Apo-1, CD95) receptor expression in childhood astrocytomas. Is it a marker of the major apoptotic pathway or a signaling receptor for immune escape of neoplastic cells?
Bodey B; Bodey B; Siegel SE; Kaiser HE
In Vivo; 1999; 13(4):357-73. PubMed ID: 10586378
[TBL] [Abstract][Full Text] [Related]
12. Astrocyte-specific expression of CDK4 is not sufficient for tumor formation, but cooperates with p53 heterozygosity to provide a growth advantage for astrocytes in vivo.
Huang ZY; Baldwin RL; Hedrick NM; Gutmann DH
Oncogene; 2002 Feb; 21(9):1325-34. PubMed ID: 11857076
[TBL] [Abstract][Full Text] [Related]
13. Expression of bcl-2, bax and bcl-xl in human gliomas: a re-appraisal.
Martin S; Toquet C; Oliver L; Cartron PF; Perrin P; Meflah K; Cuillère P; Vallette FM
J Neurooncol; 2001 Apr; 52(2):129-39. PubMed ID: 11508812
[TBL] [Abstract][Full Text] [Related]
14. A histopathological contribution to supratentorial glioma grading, definition of mixed gliomas and recognition of low grade glioma with Rosenthal fibers.
Cillekens JM; Beliën JA; van der Valk P; Faes TJ; van Diest PJ; Broeckaert MA; Kralendonk JH; Kamphorst W
J Neurooncol; 2000; 46(1):23-43. PubMed ID: 10896203
[TBL] [Abstract][Full Text] [Related]
15. Suppression of Rac activity induces apoptosis of human glioma cells but not normal human astrocytes.
Senger DL; Tudan C; Guiot MC; Mazzoni IE; Molenkamp G; LeBlanc R; Antel J; Olivier A; Snipes GJ; Kaplan DR
Cancer Res; 2002 Apr; 62(7):2131-40. PubMed ID: 11929835
[TBL] [Abstract][Full Text] [Related]
16. Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma.
Leins A; Riva P; Lindstedt R; Davidoff MS; Mehraein P; Weis S
Cancer; 2003 Dec; 98(11):2430-9. PubMed ID: 14635078
[TBL] [Abstract][Full Text] [Related]
17. Expression of oligodendrocytic mRNAs in glial tumors: changes associated with tumor grade and extent of neoplastic infiltration.
Landry CF; Verity MA; Cherman L; Kashima T; Black K; Yates A; Campagnoni AT
Cancer Res; 1997 Sep; 57(18):4098-104. PubMed ID: 9307299
[TBL] [Abstract][Full Text] [Related]
18. Cyclin D1 expression in gliomas.
Cavalla P; Dutto A; Piva R; Richiardi P; Grosso R; Schiffer D
Acta Neuropathol; 1998 Feb; 95(2):131-5. PubMed ID: 9498046
[TBL] [Abstract][Full Text] [Related]
19. Expression pattern of alpha-protein kinase C in human astrocytomas indicates a role in malignant progression.
Benzil DL; Finkelstein SD; Epstein MH; Finch PW
Cancer Res; 1992 May; 52(10):2951-6. PubMed ID: 1316231
[TBL] [Abstract][Full Text] [Related]
20. Akt pathway activation converts anaplastic astrocytoma to glioblastoma multiforme in a human astrocyte model of glioma.
Sonoda Y; Ozawa T; Aldape KD; Deen DF; Berger MS; Pieper RO
Cancer Res; 2001 Sep; 61(18):6674-8. PubMed ID: 11559533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
